Nrx pharmaceuticals leaders to present at the h.c. wainwright & co. global investment conference

Company to present corporate update during investor webcast, may 24, 2022, at 7:00am et radnor, pa. , may 19, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), a clinical-stage biopharmaceutical company, today announced its interim chief executive officer, robert besthof, and other executive leaders will be presenting a virtual update to the company's business via webcast at the h.c.
NRXP Ratings Summary
NRXP Quant Ranking